Bear Creek Capital Presents Biosig Technologies Inc.-Orlando Dinner
Other
7488 West Sand Lake Road,Orlando FL 32819
21 April, 2021
Description
Come have meet and learn more about BioSig Technologies, Inc. and their management team. *Due to limited seating, please make sure each individual registers accordingly. You will not be permitted to attend the event without proper registration. Bear Creek Capital Presents:Dinner & Corporate PresentationBioSig Technologies, Inc. ( NASDAQ: BSGM)Wednesday, April 21, 2021Eddie V's Prime Seafood7488 W Sand Lake RoadOrlando, FL 32819Promptly at 5:30 PM About BioSig Technologies, Inc.BioSig Technologies is a medical technology company developing a proprietary biomedical signal processing platform designed to improve the electrophysiology (EP) marketplace (www.biosig.com).The Company’s first product, PURE EP(tm) System is a computerized system intended for acquiring, digitizing, amplifying, filtering, measuring and calculating, displaying, recording and storing of electrocardiographic and intracardiac signals for patients undergoing electrophysiology (EP) procedures in an EP laboratory.In the NewsBioSig Invited to Join Alliance for Artificial Intelligence in Healthcare (AAIH) EP Lab Digest Features Physician Experience with BioSig’s Cardiac Signal Acquisition Technology BioSig lands Commercial Sales to Leading Hospital System BioSig Awarded U.S. Patent Claims for the Noise-Filtering Methods for its Signal Processing Technology BioSig Issues Shareholder Letter with Corporate Update on Recent Achievements and Anticipated Milestones for 2021 BioSig Awarded U.S. Patent Claims for its NeuroClear™ Subsidiary BioSig Appoints Brenda Castrodad to Lead Human Resources Major Medical Centers Enter into Installation Agreements for Evaluation of BioSig PURE EP™ Systems BioSig and Mayo Clinic Collaborate on New R&D Program to Develop Transformative AI and Machine Learning Technologies for its PURE EP™ System Presentation Format: 5:30 p.m. to 7:30 p.m. – Presentation and Dinner Contact: Raymond Oliver CEO, Bear Creek Capital 321-439-2120 [email protected]
Discussion
By posting you agree to the Terms and Privacy Policy.